Enter assignee name

EPO Patents = 1

Forward Citations = 130

Loading Chart...

11 inventors (with patents filed for the assignee):

Jeffrey Alan Stafford (9 out of 143 patents)

James Marvin Veal (8 out of 104 patents)

Zhe Nie (5 out of 47 patents)

4. Toufike Kanouni (5 out of 86 patents)

5. Young K Chen (4 out of 63 patents)

6. Michael Brennan Wallace (4 out of 94 patents)

7. Stephen W Kaldor (2 out of 68 patents)

8. Amogh Boloor (2 out of 33 patents)

9. Michael John Bennett (2 out of 11 patents)

10. Michael Brennen Wallace (2 out of 2 patents)

11. Juan Manuel Betancort (1 out of 19 patents)

10 patents: Sort by Forward Citations

1. 9255097 - Inhibitors of lysine specific demethylase-1 (2016-02-09),

2. 9242968 - Histone demethylase inhibitors (2016-01-26),

3. 9133166 - Histone demethylase inhibitors (2015-09-15),

4. 9115114 - Bromodomain inhibitors (2015-08-25),

5. 9107916 - Histone demethylase inhibitors (2015-08-18),

6. 9085534 - Histone demethylase inhibitors (2015-07-21),

7. 9034900 - Bromodomain inhibitors (2015-05-19),

8. 8987461 - Histone demethylase inhibitors (2015-03-24),

9. 8969343 - Histone demethylase inhibitors (2015-03-03),

10. 8952151 - Histone demethylase inhibitors (2015-02-10),

Quanticel Pharmaceuticals, Inc. is a biotechnology company based in San Diego, California, focused on developing innovative therapies for cancer treatment. The company specializes in harnessing advanced technologies to identify and target cancer stem cells, aiming to improve patient outcomes through precision medicine. Quanticel's research efforts are centered on understanding the complexities of tumor biology, which positions it at the forefront of cancer research and therapeutic development.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

10 Patents

#534 in San Diego, CA

#7,108 in California

#29,839 in US

#55,986 in the World

San Diego, CA, United States of America

Quanticel Pharmaceuticals, Inc.